Market Access News | pharmaphorum

News

Roche has claimed a CE Mark in the EU for an AI algorithm that can help doctors decide whether patients with chest pain are having a heart attack.

News

Pharming's Joenja has become the first disease-modifying drug that can be used by the NHS to treat APDS, an ultra-rare immunodeficiency disorder.

News

Roche will spend $50bn on manufacturing and R&D facilities in the US, with a pledge to export more medicines from the US than it imports.

Market Access

Dupixent's seventh indication is chronic hives, where a new treatment hasn't been approved since Novartis's Xolair in 2014

Market Access

The announcement signals a new administration attempting to distance itself from industry, but the actual impact seems small.

News

The WHO has concluded negotiations on a 30-page draft agreement on pandemic preparedness. It goes before the assembly for consideration in May.